Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Umbricht

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Scientific Reports|November 30, 2019
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617Christoph A Umbricht, Ulli Köster, Peter Bernhardt, et al.
The Prostate|June 25, 2019
Concentration-dependent effects of dutasteride on prostate-specific membrane antigen (PSMA) expression and uptake of <sup>177</sup> Lu-PSMA-617 in LNCaP cellsBenedikt Kranzbühler, Souzan Salemi, Christoph A Umbricht, et al.
Drug and Alcohol Dependence|June 1, 1996
Increasing opiate abstinence through voucher-based reinforcement therapyK Silverman, C J Wong, S T Higgins, et al.
Molecules (Basel, Switzerland)|October 17, 2020
Developments toward the Implementation of <sup>44</sup>Sc Production at a Medical CyclotronNicholas P van der Meulen, Roger Hasler, Zeynep Talip, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2019
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancerCristina Müller, Christoph A Umbricht, Nadezda Gracheva, et al.
Drug and Alcohol Dependence|February 13, 2001
Family history influence on drug abuse severity and treatment outcomeR W Pickens, K L Preston, D R Miles, et al.
EJNMMI Research|July 27, 2019
Preclinical investigations and first-in-human application of <sup>152</sup>Tb-PSMA-617 for PET/CT imaging of prostate cancerCristina Müller, Aviral Singh, Christoph A Umbricht, et al.
Pharmaceutics|September 5, 2019
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer InstituteCristina Müller, Maria De Prado Leal, Marco D Dominietto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2020
Biodistribution and dosimetry of a single dose of albumin-binding ligand [<sup>177</sup>Lu]Lu-PSMA-ALB-56 in patients with mCRPCVasko Kramer, René Fernández, Wencke Lehnert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 10, 2019
First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for <sup>68</sup>Ga-PSMA-11 in Salivary GlandsNiels J Rupp, Christoph A Umbricht, Daniele A Pizzuto, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Scientific Reports|November 30, 2019
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617Christoph A Umbricht, Ulli Köster, Peter Bernhardt, et al.
The Prostate|June 25, 2019
Concentration-dependent effects of dutasteride on prostate-specific membrane antigen (PSMA) expression and uptake of <sup>177</sup> Lu-PSMA-617 in LNCaP cellsBenedikt Kranzbühler, Souzan Salemi, Christoph A Umbricht, et al.
Drug and Alcohol Dependence|June 1, 1996
Increasing opiate abstinence through voucher-based reinforcement therapyK Silverman, C J Wong, S T Higgins, et al.
Molecules (Basel, Switzerland)|October 17, 2020
Developments toward the Implementation of <sup>44</sup>Sc Production at a Medical CyclotronNicholas P van der Meulen, Roger Hasler, Zeynep Talip, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2019
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancerCristina Müller, Christoph A Umbricht, Nadezda Gracheva, et al.
Drug and Alcohol Dependence|February 13, 2001
Family history influence on drug abuse severity and treatment outcomeR W Pickens, K L Preston, D R Miles, et al.
EJNMMI Research|July 27, 2019
Preclinical investigations and first-in-human application of <sup>152</sup>Tb-PSMA-617 for PET/CT imaging of prostate cancerCristina Müller, Aviral Singh, Christoph A Umbricht, et al.
Pharmaceutics|September 5, 2019
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer InstituteCristina Müller, Maria De Prado Leal, Marco D Dominietto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2020
Biodistribution and dosimetry of a single dose of albumin-binding ligand [<sup>177</sup>Lu]Lu-PSMA-ALB-56 in patients with mCRPCVasko Kramer, René Fernández, Wencke Lehnert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 10, 2019
First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for <sup>68</sup>Ga-PSMA-11 in Salivary GlandsNiels J Rupp, Christoph A Umbricht, Daniele A Pizzuto, et al.
Pageof 3